MILLENNIUM MANAGEMENT LLC - LYELL IMMUNOPHARMA INC ownership

LYELL IMMUNOPHARMA INC's ticker is LYEL and the CUSIP is 55083R104. A total of 76 filers reported holding LYELL IMMUNOPHARMA INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 1.6%.

Quarter-by-quarter ownership
MILLENNIUM MANAGEMENT LLC ownership history of LYELL IMMUNOPHARMA INC
ValueSharesWeighting
Q3 2023$287,407
-56.7%
195,515
-6.3%
0.00%
Q2 2023$663,577
+81220.7%
208,672
-39.7%
0.00%
Q1 2023$816
-99.9%
345,955
+22.7%
0.00%
-100.0%
Q1 2022$1,423,000
-52.7%
281,855
-27.4%
0.00%
-50.0%
Q4 2021$3,006,000
+209.9%
388,381
+492.8%
0.00%
+100.0%
Q3 2021$970,000
-54.5%
65,515
-50.0%
0.00%0.0%
Q2 2021$2,130,000131,1500.00%
Other shareholders
LYELL IMMUNOPHARMA INC shareholders Q2 2022
NameSharesValueWeighting ↓
MWG Management Ltd. 20,162,332$131,458,00059.13%
Apoletto Ltd 15,093,969$98,413,00027.22%
Foresite Capital Management IV, LLC 13,282,181$86,600,00023.32%
MIC Capital Management UK LLP 3,060,569$19,955,0003.90%
Alphabet Inc. 5,865,125$38,241,0002.08%
HSG Holding Ltd 3,045,997$19,860,0001.83%
Board of Trustees of The Leland Stanford Junior University 1,647,882$10,744,0000.72%
SG3 Management, LLC 600,000$3,912,0000.46%
KETTLE HILL CAPITAL MANAGEMENT, LLC 157,700$1,028,0000.26%
Artal Group S.A. 700,000$4,564,0000.24%
View complete list of LYELL IMMUNOPHARMA INC shareholders